Eli Lilly said the FDA won't approve its new drug application for a type-2 diabetes treatment until issues at the product manufacturing facility are resolved.
via WSJ.com: US Business http://ift.tt/1drfIMa
via WSJ.com: US Business http://ift.tt/1drfIMa
Nessun commento:
Posta un commento